
| Aripiprazole Basic information |
| Product Name: | Aripiprazole |
| Synonyms: | ARIPIPRAZOLE;ARIPIPRAZOLE-D8;ABILIFY;ABILITAT;7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril;OPC 14597;OPC 31;7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone |
| CAS: | 129722-12-9 |
| MF: | C23H27Cl2N3O2 |
| MW: | 448.39 |
| EINECS: | |
| Product Categories: | INORGANIC & ORGANIC CHEMICALS;Active Pharmaceutical Ingredients;API;Heterocyclic Compounds;Chemistry;Intermediates & Fine Chemicals;Neurochemicals;Pharmaceuticals;Isotope Labeled Compounds;Heterocycles |
| Mol File: | 129722-12-9.mol |
![]() | |
| Aripiprazole Chemical Properties |
| mp | 139°C |
| storage temp. | -20°C Freezer |
| CAS DataBase Reference | 129722-12-9(CAS DataBase Reference) |
| Safety Information |
| HS Code | 29349990 |
| Hazardous Substances Data | 129722-12-9(Hazardous Substances Data) |
| MSDS Information |
| Provider | Language |
|---|---|
| Aripiprazole | English |
| Aripiprazole Usage And Synthesis |
| Chemical Properties | Colourless Flake Crystalline Solid |
| Usage | A deuterated version of Aripiprazole, a selective dopamine D2-receptor antagonist with dopamine autoreceptor agonist activity. Please note that users have reported separation of this compound and aripiprazole under normal-phase and reverse-phase |